Regulation of the interleukin-7 receptor α promoter by the Ets transcription factors PU. 1 and GA-binding protein in developing B cells RP DeKoter, BL Schweitzer, MB Kamath, D Jones, H Tagoh, C Bonifer, ... Journal of Biological Chemistry 282 (19), 14194-14204, 2007 | 83 | 2007 |
Generation of an algorithm based on minimal gene sets to clinically subtype triple negative breast cancer patients BZ Ring, DR Hout, SW Morris, K Lawrence, BL Schweitzer, DB Bailey, ... BMC cancer 16 (1), 1-8, 2016 | 76 | 2016 |
Cutting edge: K63-linked polyubiquitination of NEMO modulates TLR signaling and inflammation in vivo CY Ni, ZH Wu, WC Florence, VV Parekh, MP Arrate, S Pierce, ... The Journal of Immunology 180 (11), 7107-7111, 2008 | 64 | 2008 |
Analysis of gene expression and Ig transcription in PU. 1/Spi-B-deficient progenitor B cell lines BL Schweitzer, RP DeKoter The Journal of Immunology 172 (1), 144-154, 2004 | 63 | 2004 |
Reduction in PU. 1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality IB Houston, MB Kamath, BL Schweitzer, TM Chlon, RP DeKoter Experimental hematology 35 (7), 1056-1068, 2007 | 54 | 2007 |
Spi-C has opposing effects to PU. 1 on gene expression in progenitor B cells BL Schweitzer, KJ Huang, MB Kamath, AV Emelyanov, BK Birshtein, ... The Journal of Immunology 177 (4), 2195-2207, 2006 | 38 | 2006 |
Comparison of triple-negative breast cancer molecular subtyping using RNA from matched fresh-frozen versus formalin-fixed paraffin-embedded tissue B Jovanović, Q Sheng, RS Seitz, KD Lawrence, SW Morris, LR Thomas, ... BMC cancer 17 (1), 1-14, 2017 | 31 | 2017 |
Performance of a RT-PCR assay in comparison to FISH and immunohistochemistry for the detection of ALK in non-small cell lung cancer DR Hout, BL Schweitzer, K Lawrence, SW Morris, T Tucker, R Mazzola, ... Cancers 9 (8), 99, 2017 | 24 | 2017 |
Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for … JR Espinosa Fernandez, BL Eckhardt, J Lee, B Lim, T Pearson, RS Seitz, ... PloS one 15 (4), e0231953, 2020 | 22 | 2020 |
A novel immuno-oncology algorithm measuring tumor microenvironment to predict response to immunotherapies TJ Nielsen, BZ Ring, RS Seitz, DR Hout, BL Schweitzer Heliyon 7 (3), e06438, 2021 | 20 | 2021 |
Transgenic expression of Spi‐C impairs B‐cell development and function by affecting genes associated with BCR signaling X Zhu, BL Schweitzer, EJ Romer, CEW Sulentic, RP DeKoter European journal of immunology 38 (9), 2587-2599, 2008 | 20 | 2008 |
Characterization of the tumor immune-microenvironment of adenocarcinoma of lung with a metastatic lesion in the pancreas treated successfully with first-line, single-agent … DL Saltman, TJ Nielsen, D Salina, DR Hout, FB McMahon, BR Valev, ... Therapeutic Advances in Medical Oncology 13, 17588359211010156, 2021 | 4 | 2021 |
One-year progression-free survival in lung cancer patients treated with immune checkpoint inhibitors is significantly associated with a novel immunomodulatory signature but not … H Ranganath, A Jain, J Smith, J Ryder, A Chaudry, E Miller, F Hare, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 7, 2019 | 4 | 2019 |
KIT COMPRISING PRIMERS FOR AMPLIFYING ALK KINASE DOMAIN NUCLEIC ACIDS DR Hout, R Skelton, J Handshoe, K Lawrence, B Schweitzer US Patent 20,150,307,944, 2015 | 4 | 2015 |
A prospective study to compare qPCR to IHC and FISH for the detection of anaplastic lymphoma kinase (ALK) fusions in FFPE specimens from NSCLC patients (PCRTALK). DR Hout, J Handshoe, B Schweitzer, SW Morris, A Karsan, H Daudt, ... ASCO Annual Meeting Proceedings 32 (15_suppl), TPS11136, 2014 | 4 | 2014 |
Validation of an immunomodulatory gene signature algorithm to predict response to neoadjuvant immunochemotherapy in patients with primary triple-negative breast cancer. T Iwase, L Pusztai, K Blenman, X Li, R Seitz, TJ Nielsen, BL Schweitzer, ... Journal of Clinical Oncology 38 (15_suppl), 3117-3117, 2020 | 3 | 2020 |
Novel qPCR screen for efficient and reliable identification of RET fusion-positive non-small cell lung cancer. BL Schweitzer, RB Smith, R Skelton, R Vincent, F McMahon, J Handshoe, ... ASCO Annual Meeting Proceedings 33 (15_suppl), e22154, 2015 | 2 | 2015 |
Validation of a 27-gene immuno-oncology algorithm in metastatic urothelial carcinoma treated with an immune checkpoint inhibitor RS Seitz, DT Ross, TJ Nielsen, DR Hout, BL Schweitzer Cancer Research 81 (13 Supplement), 23-23, 2021 | 1 | 2021 |
Pathway modeling to translate the 27-gene immuno-oncology algorithm into bladder cancer RS Seitz, TJ Nielsen, BL Schweitzer, DR Hout, DT Ross Cancer Research 81 (13 Supplement), 175-175, 2021 | 1 | 2021 |
The unknown piece of the pie: Molecular markers in triple-negative lung cancer. BL Schweitzer, KD Lawrence, J Handshoe, R Skelton, L Chatfield, L Xue, ... Cancer Research 73 (8 Supplement), 1930-1930, 2013 | 1 | 2013 |